Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma
返回论文页
Full-length article|更新时间:2022-06-24
|
Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma
Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma
Genes & Diseases2022年9卷第3期
作者机构:
1. Department of Pathology and Cell Biology, and Columbia University,NY,New York,USA,10032
2. Department of Otolaryngology, Columbia University,NY,New York,USA,10032
3. Department of Otolaryngology, Vanderbilt University,TN,Nashville,USA,37232
4. Department of Otolaryngology, Hospital Universitario Central de Asturias and Instituto Universitario de Oncología Del Principado de Asturias, Oviedo,Spain,33006
Andrew T. Turk, Dario Garcia-Carracedo, David T. Kent, 等. Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma[J]. Genes & Diseases, 2022,9(3).
Andrew T. Turk, Dario Garcia-Carracedo, David T. Kent, et al. Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma[J]. Genes & Diseases, 2022,9(3).
Andrew T. Turk, Dario Garcia-Carracedo, David T. Kent, 等. Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma[J]. Genes & Diseases, 2022,9(3). DOI: 10.1016/j.gendis.2020.12.002.
Andrew T. Turk, Dario Garcia-Carracedo, David T. Kent, et al. Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma[J]. Genes & Diseases, 2022,9(3). DOI: 10.1016/j.gendis.2020.12.002.
Stathmin as a surrogate marker of phosphatidylinositol-3-kinase pathway activity: Towards precision medicine in HPV-negative head & neck squamous cell carcinoma
摘要
Abstract
In order to assess Stathmin as an immunohistochemical (IHC) indicator of phosphatidylinositol 3-kinase (PI3K) pathway activity in HPV-negative head & neck squamous cell carcinoma (HNSCC)
we compared Stathmin IHC to expression of other pathway components. We also evaluated the relationship between Stathmin IHC and the mutational status of four key pathway genes. Finally
we ascertained whether Stathmin IHC correlates with tumor grade or primary site. Correlation exists between high Stathmin expression and high pAKT1 expression
indicating a role for Stathmin IHC as a marker of pathway activity. Our analysis did not show correlation between Stathmin IHC and mutation of the four genes evaluated. We also observed an association between high Stathmin expression and oropharyngeal primary site. Our results suggest utility of Stathmin IHC as an indicator of PI3K pathway activity
and thereby demonstrate potential relevance of Stathmin IHC in the context of HNSCC.